179 related articles for article (PubMed ID: 23278899)
1. Extract of Aneilema keisak inhibits transforming growth factor-β-dependent signalling by inducing Smad2 downregulation in keloid fibroblasts.
Kim WS; Lee JS; Bae GY; Kim JJ; Chin YW; Bahk YY; Min HG; Cha HJ
Exp Dermatol; 2013 Jan; 22(1):69-71. PubMed ID: 23278899
[TBL] [Abstract][Full Text] [Related]
2. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
3. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids.
Cho JW; Il KJ; Lee KS
Int J Mol Med; 2013 May; 31(5):1148-52. PubMed ID: 23503720
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
[TBL] [Abstract][Full Text] [Related]
6. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y
Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway.
Nagar H; Kim S; Lee I; Kim S; Choi SJ; Piao S; Jeon BH; Oh SH; Kim CS
Sci Rep; 2021 Jan; 11(1):500. PubMed ID: 33436666
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
Wang W; Qu M; Xu L; Wu X; Gao Z; Gu T; Zhang W; Ding X; Liu W; Chen YL
J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758
[TBL] [Abstract][Full Text] [Related]
9. Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid.
Hsu YC; Chen MJ; Yu YM; Ko SY; Chang CC
Arch Dermatol Res; 2010 Dec; 302(10):717-24. PubMed ID: 20717830
[TBL] [Abstract][Full Text] [Related]
10. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
Zhang Y; Cheng C; Wang S; Xu M; Zhang D; Zeng W
Life Sci; 2019 Sep; 232():116637. PubMed ID: 31288014
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-133a-3p inhibits fibrosis and proliferation of keloid fibroblasts by regulating IRF5 to inhibit the TGF-β/Smad2 pathway.
Huang Y; Wang Y; Lin L; Wang P; Jiang L; Liu J; Wang X
Mol Cell Probes; 2020 Aug; 52():101563. PubMed ID: 32205184
[TBL] [Abstract][Full Text] [Related]
13. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.
Chua AW; Gan SU; Ting Y; Fu Z; Lim CK; Song C; Sabapathy K; Phan TT
J Dermatol Sci; 2011 Dec; 64(3):199-209. PubMed ID: 22005028
[TBL] [Abstract][Full Text] [Related]
14. Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA.
Gao Z; Wang Z; Shi Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhao Y; Wu H; Jin Y
Plast Reconstr Surg; 2006 Nov; 118(6):1328-1337. PubMed ID: 17051103
[TBL] [Abstract][Full Text] [Related]
15. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A
In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007
[TBL] [Abstract][Full Text] [Related]
16. Aspidin PB, a novel natural anti-fibrotic compound, inhibited fibrogenesis in TGF-β1-stimulated keloid fibroblasts via PI-3K/Akt and Smad signaling pathways.
Song R; Li G; Li S
Chem Biol Interact; 2015 Aug; 238():66-73. PubMed ID: 26054450
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways.
Tang M; Bian W; Cheng L; Zhang L; Jin R; Wang W; Zhang Y
Int J Mol Med; 2018 Mar; 41(3):1487-1499. PubMed ID: 29328420
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of elF3a inhibits TGF‑β1‑induced extracellular matrix protein expression in keloid fibroblasts.
Li T; Zhao J
Mol Med Rep; 2018 Mar; 17(3):4057-4061. PubMed ID: 29286129
[TBL] [Abstract][Full Text] [Related]
19. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
Phan TT; Lim IJ; Aalami O; Lorget F; Khoo A; Tan EK; Mukhopadhyay A; Longaker MT
J Pathol; 2005 Oct; 207(2):232-42. PubMed ID: 16052471
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 modulates extracellular matrix production and TGF-beta signaling in cultured human subconjunctival fibroblasts.
Yamanaka O; Saika S; Ikeda K; Miyazaki K; Ohnishi Y; Ooshima A
Curr Eye Res; 2006 Jun; 31(6):491-9. PubMed ID: 16769608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]